| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.3 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |